Effect of liposome-encapsulated clodronate pretreatment on synthetic vector-mediated gene expression in mice

Gene Therapy

Volumn 6, Issue 3, 1999, Pages 448-453

  Schughart, K ^a   Bischoff, R ^b   Hadji, D Ali ^a   Boussif, O ^a   Perraud, F ^a   Accart, N ^a   Rasmussen, U B ^a   Pavirani, A ^a   Van Rooijen, N ^c   Kolbe, H V J ^a  

^a TRANSGENE S A   (France)

^b Astra Draco AB ^*  (Sweden)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Glycerolipoplexes; In vivo gene transfer; Liposome encapsulated clodronate; Polyethylenimine polyplexes; Synthetic vectors

Indexed keywords

CLODRONIC ACID; LIPOSOME; LUCIFERASE; POLYETHYLENEIMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENCAPSULATION; EXPRESSION VECTOR; GENE EXPRESSION; GENE THERAPY; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE;

ANIMALS; CLODRONIC ACID; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GLYCEROL; INJECTIONS, INTRAVENOUS; LIPOSOMES; LUCIFERASES; LUNG; MICE; POLYETHYLENEIMINE;

EID: 0033040203     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300826     Document Type: Article

References (34)

1. Wheeler CJ et al. A novel cationic lipid greatly enhances plasmid DNA delivery and expression in the mouse lung. Proc Natl Acad Sci 1996; 93: 11454-11459.
2. Lee ER et al. Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung. Hum Gene Ther 1996; 7: 1701-1717.
3. Song YK, Liu F, Chu S, Liu D. Characterisation of cationic-liposome mediated gene transfer in vivo by intravenous administration. Hum Gene Ther 1997; 8: 1585-1594.
4. Hara T, Tan Y, Huang L. In vivo gene delivery to the liver using reconstituted chylomicron remnants as a novel nonviral vector. Proc Natl Acad Sci USA 1997; 94: 14547-14552.
5. Liu F, Qi H, Liu D. Factors controlling the efficiency of cationic lipid-mediated transfection in vivo via intravenous administration. Gene Therapy 1997; 4: 517-523.
6. Templeton NS et al. Improved DNA:liposome complexes for increased systemic delivery and gene expression. Nat Biotechnol 1997; 15: 647-652.
7. Li S, Huang L. In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes. Gene Therapy 1997; 4: 891-900.
8. Barron LG, Meyer KB, Szoka FC. Effect of complement depletion on the pharmacokinetics and gene delivery mediated by cationic lipid-DNA complexes. Hum Gene Ther 1998; 9: 315-323.
9. Hong K, Zheng W, Baker A, Papahadjopoulos D. Stabilisation of cationic liposome-plasmid DNA complexes by polyamines and poly(ethylene glycol)-phospholipid conjugates for efficient in vivo gene delivery. FEBS Lett 1997; 400: 233-237.
10. Liu Y et al. Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery. Nat Biotechnol 1997; 15: 167-173.
11. Mahato RI, Holland A, Tomlinson E. Cationic lipid-based gene delivery systems: pharmaceutical perspectives. Pharm Res 1997; 14: 853-859.
12. Lee RJ, Huang L. Lipidic vector systems for gene transfer. Crit Rev Ther Drug Carrier Syst 1997; 14: 173-206.
13. Kabanov AV, Felgner PL, Seymour LW. Self-assembling Complexes for Gene Delivery. John Wiley & Sons: Chichester, 1998.
14. Boletta A et al. Nonviral gene delivery to the rat kidney with polyethylenimine. Hum Gene Ther 1997; 8: 1243-1251.
15. Boussif O et al. A novel, versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci USA 1995; 92: 7297-7303.
16. Wu GY et al. Receptor-mediated gene delivery in vivo. J Biol Chem 1991; 266: 14338-14342.
17. Demeneix BA et al. Delivery of polynucleotides with polyamine lipids and polymers. Nucleosides Nucleotides 1997; 16: 1121-1127.
18. Abdallah B, Sachs L, Demeneix BA. Non-viral gene transfer: applications in developmental biology and gene therapy. Biol Cell 1995; 85: 1-7.
19. Litzinger DC et al. Fate of cationic liposomes and their complex with oligonucleotide in vivo. Biochim Biophys Acta 1996; 1281: 139-149.
20. van Rooijen N, Kors N, vd Ende M, Dijkstra CD. Depletion and repopulation of macrophages in spleen and liver after intravenous treatment with liposome-encapsulated dichloromethylene diphosphonate. Cell Tissue Res 1990; 260: 215-222.
21. van Rooijen N, Sanders A. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J Immunol Meth 1994; 174: 83-93.
22. Plosker GL, Goa KL. Clodronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease. Drugs 1994; 47: 945-982.
23. Kuzmin AI, Finegold MJ, Eisensmith RC. Macrophage depletion increases the safety, efficacy and persistence of adenovirus-mediated gene transfer in vivo. Gene Therapy 1997; 4: 309-316.
24. Wolff G et al. Enhancement of in vivo adenovirus-mediated gene transfer and expression by prior depletion of tissue macrophages in the target organ. J Virol 1997; 71: 624-629.
25. Worgall S et al. Role of alveolar macrophages in rapid elimination of adenovirus vectors administered to the epithelial surface of the respiratory tract. Hum Gene Ther 1997; 8: 1675-1684.
26. McLean JW et al. Organ-specific endothelial cell uptake of cationic liposome-DNA complexes in mice. Am J Physiol 1997; 273: H387-H404.
27. Thurston G et al. Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice. J Clin Invest 1998; 101: 1401-1413.
28. Devine DV et al. Liposome-complement interactions in rot serum: implications for liposome survival studies. Biochim Biophys Acta 1994; 1191: 43-51.
29. Plank C, Mechtler K, Szoka FC, Wagner E. Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery. Hum Gene Ther 1996; 7: 1437-1446.
30. Zelphati O, Uyechi LS, Barron LG, Szoka FC. Effect of serum components on the physico-chemical properties of cationic lipid/oligonucleotide complexes and their interactions with cells. Biochim Biophys Acta 1998; 1390: 119-133.
31. Thepen T, van Rooijen N, Kraal G. Alveolar macrophage elimination in vivo is associated with an increase in pulmonary immune response in mice. J Exp Med 1989; 170: 499-509.
32. Austyn JM, Gordon S. F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur J Immunol 1981; 11: 805-815.
33. Zanta MA, Boussif O, Adib A, Behr JP. In vitro gene delivery to hepatocytes with galactosylated polyethylenimine. Bioconjug Chem 1997; 8: 839-844.
34. Luskey KL. Structure and expression of 3-hydroxy 3-methylglutaryl coenzyme A reductase. Ann NY Acad Sci 1986; 478: 249-254.